Literature DB >> 12766783

The epidemiology of colorectal cancer: what can we learn from the New Zealand Cancer Registry?

John Keating1, Peter Pater, Simi Lolohea, Kesara Wickremesekera.   

Abstract

AIM: Colorectal cancer (CRC) is a major cause of cancer death in New Zealand. Incidence and mortality rates are regularly reported but more detailed information concerning the epidemiology of the disease is not readily available. The aim of this study is to describe the epidemiology of colorectal cancer, with particular reference to gender; subsite distribution; stage at diagnosis; tumour grade; the contribution of recognisable aetiological factors; and the resection rate and type of surgery performed for rectal cancer.
METHODS: All 2272 pathology reports of colorectal cancer submitted to the National Cancer Registry for the year 2000 were reviewed and restaged according to the classical Dukes system. Age, gender, stage, subsite distribution, differentiation, tumour type, associated pathology and type of rectal cancer specimen were recorded.
RESULTS: The gender ratio for all cases was equal. One third of resected cancers were in the rectum, one third in the left colon and one third were proximal to the splenic flexure. Men had more rectal cancer (M:F 1.6:1) and women more colon cancer (0.9:1). Right-sided cancers were of significantly higher grade than left-sided cancers. The proportion of right-sided cancers increased with advancing age in both men and women. Three per cent of patients had synchronous tumours and 0.2% of patients had phenotypic features of familial adenomatous polyposis (FAP). Fourteen per cent of patients were Dukes stage A at diagnosis, 43% stage B and 43% stage C. Rectal cancers were more likely to be stage A than colon cancers (odds ratio 1.6). Stage and grade of CRC were significantly associated. Ninety one per cent of cancers were resected; 29% of patients with rectal cancer had an abdominoperineal resection and 6% a local excision.
CONCLUSIONS: The current stage distribution of CRC is in keeping with a predominantly unscreened population. The subsite distribution of cancer and its relationship to age and gender are similar to other high-risk countries; however, its relationship to grade of tumour has not previously been reported. An abdominoperineal resection rate of 29% reflects the mix of specialised colorectal and general surgical units treating rectal cancer in New Zealand and is in line with or better than recent overseas data that reflect national or regional practice.

Entities:  

Mesh:

Year:  2003        PMID: 12766783

Source DB:  PubMed          Journal:  N Z Med J        ISSN: 0028-8446


  9 in total

1.  Differences in characteristics of colorectal neoplasm between young and elderly Thais.

Authors:  Rungsun Rerknimitr; Winudda Ratanapanich; Pradermchai Kongkam; Pinit Kullavanijaya
Journal:  World J Gastroenterol       Date:  2006-12-21       Impact factor: 5.742

2.  Location in the large bowel influences the APC mutations observed in FAP adenomas.

Authors:  O C Will; S J Leedham; G Elia; R K S Phillips; S K Clark; I P M Tomlinson
Journal:  Fam Cancer       Date:  2010-09       Impact factor: 2.375

3.  Clinical analysis of eight kindreds of familial adenomatous polyposis.

Authors:  Yu-Long He; Chang-Hua Zhang; Mei-Jin Huang; Shi-Rong Cai; Wen-Hua Zhan; Jian-Ping Wang; Ji-Fu Wang
Journal:  World J Gastroenterol       Date:  2004-12-15       Impact factor: 5.742

4.  Surgical outcome of abdominoperineal resection for low rectal cancer in a Nigerian tertiary institution.

Authors:  Olusegun I Alatise; Oladejo O Lawal; Abdulrasheed K Adesunkanmi; Stephen A Osasan
Journal:  World J Surg       Date:  2009-02       Impact factor: 3.352

5.  CRC surgery trends in Kenya, 1993-2005.

Authors:  Hassan Saidi; Elly O Nyaim; Joseph W Githaiga; David Karuri
Journal:  World J Surg       Date:  2008-02       Impact factor: 3.352

6.  Colon cancer in Luxembourg: a national population-based data report, 1988-1998.

Authors:  René Scheiden; Paul Pescatore; Yolande Wagener; Nelly Kieffer; Catherine Capesius
Journal:  BMC Cancer       Date:  2005-05-24       Impact factor: 4.430

7.  SPAR - a randomised, placebo-controlled phase II trial of simvastatin in addition to standard chemotherapy and radiation in preoperative treatment for rectal cancer: an AGITG clinical trial.

Authors:  Michael B Jameson; Kirsten Gormly; David Espinoza; Wendy Hague; Gholamreza Asghari; Grahame Mark Jeffery; Timothy Jay Price; Christos Stelios Karapetis; Michael Arendse; James Armstrong; John Childs; Frank A Frizelle; Sam Ngan; Andrew Stevenson; Martinus Oostendorp; Stephen P Ackland
Journal:  BMC Cancer       Date:  2019-12-17       Impact factor: 4.430

8.  Colonoscopy practice in lagos, Nigeria: a report of an audit.

Authors:  C A Onyekwere; J N Odiagah; O O Ogunleye; C Chibututu; O A Lesi
Journal:  Diagn Ther Endosc       Date:  2013-02-27

9.  Colorectal Carcinoma Screening in Lagos, Nigeria, Are We Doing it Right?

Authors:  Charles A Onyekwere; Anthonia O Ogbera; Fatima B Abdulkareem; John Ashindoitiang
Journal:  Gastroenterology Res       Date:  2009-01-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.